Follow us:

News & events

  • Home
  • News & informations

Bioprocessing Summit Europe Virtual

Online, 16th-17th March

  • by Ypso-Facto
  • February 02, 2021
Ypso-Facto will attend Bioprocessing Summit Europe Virtual .   To discuss further,  contact us  or book a meeting with  Frédéric Cheviron .

Read more


UP-COMING WEBINAR - Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted

Online, 10th March 2021

  • by Ypso-Facto
  • February 01, 2021
Ypso-Facto co-presents a webinar entitled Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted with Christos Varsakelis of Janssen and Mark Demesmaeker of Sartorius .  Roger-Marc Nicoud will present his views on Using predictive digital...

Read more


BIOKET Digital Edition

Online, 1st-19th March 2021

  • by Ypso-Facto
  • February 01, 2021
Ypso-Facto will attend BIOKET Digital Edition . Join in to listen to Yohann Le Guennec's presentation on "Modeling and simulation of ion-exchange in bioprocesses". To discuss further, contact us or book a meeting with Frédéric Cheviron .   Visit our knowledge center to  view...

Read more


UP-COMING WEBINAR - Deuterium in the 21st century, use in medicinal chemistry and synthetic methods

Online, 2nd March 2021, 4 pm CET

  • by Ypso-Facto
  • January 26, 2021
In this webinar, Thomas Jennequin will present insights on the use of Deuterium in medicinal chemistry and the advantages of having some deuterated positions on APIs. For instance, Deuterium can modify drug metabolization, pharmacokinetics, or toxicity. Thomas will highlight some of the challenges...

Read more


Ypso-Facto invests 1.4M€ in the development of a collaborative software suite for process design and evaluation

The company has received 800k€ from European Regional Development Fund (ERDF) to support the development of Ypso-Proxima®

  • by Ypso-Facto
  • January 14, 2021
Nancy, France, January 14th, 2021 - Ypso-Facto, a company specialized in the development and optimization of processes for the Life Sciences Industries invests 1.4M€, including € 800,000 from the European Regional Development Fund (ERDF), to support the development of its software suite Ypso-Proxima®...

Read more


NEW ARTICLE - Comparison of mAb single-use DSP processes by Sanofi using Ypso-Proxima

EASY: a disruptive mAb purification process to reduce cost of goods

  • by Ypso-Facto
  • January 08, 2021
This article [1] illustrates how Ypso-Proxima allows a rational comparison between two biopharmaceutical DSP processes. The innovative EASY mAb purification process developed by Sanofi is matched against the standard proteinA-based DSP counterpart. Relying on Proxima's process evaluation, the...

Read more


UP-COMING WEBINAR - Manufacturing in the industry 4.0 era: how to balance innovation with performance while not being disrupted

10th March, with C. Varsakelis (Janssen), Mark Demesmaeker (Sartorius) and RM Nicoud (Ypso-Facto)

  • by Ypso-Facto
  • January 07, 2021
FREE webinar! Save your seat now by registering online, here .

Read more


NEW ARTICLE – Fareva and Ypso-Facto investigate the purification of an antibiotic by ion-exchange

Using Mechanistic Modeling for Understanding Antibiotics Purification with Ion Exchange Chromatography

  • by Ypso-Facto
  • November 02, 2020
This article is based on a real industrial purification process by Fareva and highlights the power of mechanistic modeling for process development: Our client needed to change a raw material to secure his supply chain. From a process point of view, it was supposed to be seamless. However, a...

Read more


Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information